rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.
Download announcement < Back
04 Mar 2024
To Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-Executive Independent Director of the Company. The Board of Directors based on the recommendation of the Nomination and Remuneration Committee has re-appointed Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-Executive Independent Director of the Company in the category of an Independent Director (Non-Executive) w.e.f. 04th March 2024 for a second term of up to 5 (five) consecutive years subject to approval by the Shareholders of the Company.
View all announcements for Oxygenta Pharmaceutical Ltd Source: BSE India